Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boehringer Buoyed By Progress Of Oncology Pipeline

Brigimadlin Moves Into Pivotal Trials

Aug 01 2023

• By Kevin Grogan

Boehringer Ingelheim headquarters in Ingelheim, Germany — • Source: Boehringer Ingelheim (dieth+schröder-fotografie)

Related Content

Boehringer/Zealand Dual Agonist Achieves Promising Level Of Weight Loss

Jun 25 2023

BI/Lilly’s Jardiance To Face Off With AstraZeneca’s Farxiga In CKD After EU Nod

Jul 26 2023

After Jardiance Heart Failure Successes, BI And Lilly Focus On Kidney

Mar 17 2022

Boehringer Bids To Go Beyond Slowing IPF

May 16 2022

Related Companies

Boehringer Ingelheim GmbH

Eli Lilly and Company

AstraZeneca PLC

Roche Holding AG

3T Biosciences

Kinoxis Therapeutics Pty Ltd

Zealand Pharma A/S

Novo Nordisk A/S

Additional Topics

Sales & Earnings Clinical Trials Business Strategies Commercial Cancer Renal BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window